کد مقاله کد نشریه سال انتشار مقاله انگلیسی نسخه تمام متن
2129902 1401567 2016 9 صفحه PDF دانلود رایگان
عنوان انگلیسی مقاله ISI
Long-term culture of human odontoma-derived cells with a Rho kinase inhibitor
موضوعات مرتبط
علوم زیستی و بیوفناوری بیوشیمی، ژنتیک و زیست شناسی مولکولی تحقیقات سرطان
پیش نمایش صفحه اول مقاله
Long-term culture of human odontoma-derived cells with a Rho kinase inhibitor
چکیده انگلیسی


• Odontoma-derived cells (hODCs) can be expanded for a prolonged time with Y-27632.
• Y-27632 stabilizes the telomere length during the course of the long term culture.
• The long-term cultured hODCs has odontogenic phenotype in the presence of Y-27632.

Because of cellular senescence/apoptosis, no effective culture systems are available to maintain replication of cells from odontogenic tumors especially for odontoma, and, thus, the ability to isolate human odontoma-derived cells (hODCs) for functional studies is needed. The current study was undertaken to develop an approach to isolate hODCs and fully characterize the cells in vitro. The hODCs were cultured successfully with a Rho-associated protein kinase inhibitor (Y-27632) for an extended period with stabilized lengths of the telomeres to sustain a similar phenotype/property as the primary tumoral cells. While the hODCs showed stable long-term expansion with expression of major dental epithelial markers including dentin sialophosphoprotein (DSPP) even in the three-dimensional microenvironment, they lack the specific markers for the characteristics of stem cells. Moreover, cells from dental pulp showed significant up-regulation of DSPP when co-cultured with the hODCs, while control fibroblasts with the hODCs did not. Taken together, we propose that the hODCs can be isolated and expanded over the long term with Y-27632 to investigate not only the development of the hODCs but also other types of benign human tumors.

ناشر
Database: Elsevier - ScienceDirect (ساینس دایرکت)
Journal: Experimental Cell Research - Volume 347, Issue 1, 10 September 2016, Pages 232–240
نویسندگان
, , , , , , , , , , , ,